Latest news
Quantum BioPharma's Dual Strategy Targets Neurological Health with MS Drug and Alcohol Supplement - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:51 GMTQuantum BioPharma Advances Dual Strategy for Neurological Health, Targeting MS and Alcohol Misuse - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:50 GMTQuantum BioPharma Stock Surges 8.64% as Drug Development Pipeline and Biotech Potential Attract Investor Interest - kalkine.cakalkine.ca · Fri, 07 Aug 2026 14:26:00 GMTQuantum BioPharma Ltd. (CN:QNTM) Extends Decline as Clinical Risk and Weak Sentiment Pressure Shares - kalkine.cakalkine.ca · Wed, 05 Aug 2026 11:44:00 GMTQuantum BioPharma Ltd (QNTM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Wed, 05 Aug 2026 07:00:00 GMTQuantum BioPharma Reports Encouraging Preliminary Data from Midpoint of MS Imaging Study - citybuzz -citybuzz - · Tue, 04 Aug 2026 06:28:15 GMTQuantum BioPharma (QNTM) Advances MS Imaging Study With Encouraging Preliminary Results - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 19:15:00 GMTQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study with Encouraging Preliminary Results - TradingViewTradingView · Mon, 03 Aug 2026 17:15:20 GMT